BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• New York Stock Exchange Accepts InspireMD’s Plan to Regain Compliance

  InspireMD announced that the New York Stock Exchange has accepted the Company’s plan to regain compliance with the NYSE American’s stockholder’s equity continued listing standard (Part 10, Section 1003(a)(iii)).

  October 24, 2017

   · 

  4 min read
• Business

  Fluidigm Announces Agreement With the University of Zurich to Distribute histoCAT for Multiparameter Imaging Mass Cytometry Data Analysis

  Fluidigm to distribute histoCAT, the first multiparameter Imaging Mass Cytometry software that combines leading-edge image and cytometry analysis tailored to highly multiplexed imaging data in a simple and easy-to-use format.

  October 24, 2017

   · 

  4 min read
• Biotech Bay

  Fluidigm Introduces Imaging Mass Cytometry System for Highly Multiplexed Protein Detection in Tissues

  The Hyperion Imaging System provides translational researchers with an unprecedented view of complex cellular phenotypes and their relationships in the tissue microenvironment.

  October 24, 2017

   · 

  6 min read
• Deals

  Katena Products Announces the Acquisition of Rhein Medical

  Katena Products, a leading global provider of precision ophthalmic instruments, biologics, and devices to hospitals, surgical centers, and ophthalmic and optometric offices announces the purchase of Rhein Medical Inc.

  October 24, 2017

   · 

  2 min read
• Drug Development

  Arbutus Presents HBV Data at 2017 AASLD Liver Meeting

  The presentations feature multiple Arbutus pipeline programs that highlight the potential of its product candidates and the breadth of its portfolio being advanced to improve current cure rates in chronic HBV.

  October 24, 2017

   · 

  12 min read
• BioCapital

  K2M to Feature First FDA-Cleared 3D-Printed Expandable Interbody System, Industry-Leading 3D-Printed Portfolio, & Balance ACS Platform at NASS 2017

  Favorable data on K2M’s cervical spinal solutions to be presented during scientific sessions.

  October 24, 2017

   · 

  11 min read
• Policy

  Myriad Submits BRACAnalysis CDx Application for Regulatory Approval in Japan for HER2- Metastatic Breast Cancer

  Myriad estimates there are greater than 10,000 cases of HER2- metastatic breast cancer per year in Japan which would be eligible for testing with BRACAnalysis CDx.

  October 24, 2017

   · 

  6 min read
• Drug Development

  Rhizen Pharmaceuticals S.A. Announces Preclinical Data Presentations for RP4010, a Novel First-in-Class Oral Small Molecule Inhibitor of Calcium Release-Activated Calcium (CRAC) Channel at 2017 AACR-NCI-EORTC International Conference, USA

  October 24, 2017

   · 

  2 min read
• Business

  Resverlogix Announces Right of First Refusal Agreement With Hepalink USA

  Hepalink paid $8 million (the “Fee”) to Resverlogix in consideration for the right of first refusal granted.

  October 24, 2017

   · 

  4 min read
• Policy

  ContraVir Pharmaceuticals Announces National Institutes of Health Funded Study on Antiviral Activity of CRV431

  ContraVir will utilize preclinical services from the NIAID to characterize the antiviral activity of CRV431 in a humanized mouse model of hepatitis B virus infection.

  October 24, 2017

   · 

  4 min read